-
Blueberry Strengthens MENA Presence with CMA Category 5 License and Dubai Office Launch
-
Oil falls, stocks steady as Trump hails 'good' Iran talks
-
In first, French presidential candidate gives birth during campaign
-
Canada judge to decide prison term for suicide poison seller
-
A Full Moon for Every Child: STARTRADER's STARCARES Brings Support to SOS Children's Village Ho Chi Minh City
-
Meta leans into AI, smart glasses amid privacy pushback
-
Mongolian herders enlist new tech against harsher, drier climate
-
Oil prices fall after Trump hails 'good' talks with Iran
-
Tata turmoil shines light on India succession woes
-
AI political ads warp reality ahead of US midterms
-
OMP and PwC Alliance Moves Process Manufacturers from Siloed Supply Chain Planning to Unified Decisions
-
Oil prices retreat as markets welcome US-Iran talks
-
Chile's Atacama Desert blossoms with life after El Nino rains
-
French prosecutors probe secret filming of women with smart glasses
-
Drug cocktail killed former child star Hayden Panettiere: coroner
-
Trump renames AI "super intelligence," rejects international oversight
-
Trump rejects international regulation of AI
-
How is the EU approaching record fuel prices?
-
Oil prices slide, AI stock buzz fades
-
11 hurt as teen opens fire outside school in western Turkey
-
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
-
UN chief says 'Big Oil' treats atmosphere as open sewer
-
Tunisia says 2026 summer hottest on record
-
Memoir by Diana's brother goes on sale after rocking UK monarchy
-
Houthis accuse Saudi Arabia of deadly strikes as thousands flee
-
Stocks climb as oil slides, AI buzz returns
-
STARTRADER Expands Its Chinese Equity CFD Range with CXMT and Unitree Robotics
-
MEXC Launches “Real Stocks, Real Friends” with Rewards for Bringing Friends to Wall Street
-
MEXC Expands Opportunity Compass with Stock Trading Handbook to Help Crypto Users Build Investment Knowledge
-
Stocks rise on AI buzz, oil prices cool
-
Typhoon Dujuan leaves four dead in Japan, 45,000 houses without power
-
In Bangladesh, Pakistan's Jinnah photo stirs anger
-
Stocks rise on AI buzz, drop in oil prices
-
China's robot dancers limber up for America's Got Talent final
-
UK king braces as memoir by Diana's brother goes on sale
-
Green policies just good politics, says UK minister
-
Infantino proposes consulting federations to reform FIFA
-
El Nino weather pattern enters record territory: scientist
-
South Africa arrests three more suspects, after nine women murdered
-
US networks halt Trump coverage in revolt over White House ban
-
Paramount settles with US states to clear Warner Bros. mega-merger
-
NOWPayments Releases Cross-Chain Payout Data Revealing Key Performance Benchmarks Across TRON, BNB Chain, and Solana
-
Climate crisis a job for world leaders, not just activists: UK FM
-
COP31 host says AI climate footprint to be a summit priority
-
COP31 host says AI's climate footprint to be a summit priority
-
Global stocks rally on lower oil prices, US-China hopes
-
EU proposes energy rating for data centres
-
Spanish PM says unregulated AI could be 'devastating'
-
TradersYard Shifts Focus to Futures Trading
-
From Korean Chipmakers to Leveraged Semiconductor ETFs: STARTRADER Launches 49 New 24/7 Stock and ETF CFDs
OMP and PwC Alliance Moves Process Manufacturers from Siloed Supply Chain Planning to Unified Decisions
Specialty pharmaceutical company medac has moved its planners onto a single demand plan. PwC and medac present the rollout and the road ahead at OMP's Singapore event on October 15, 2026.
ANTWERPEN, BE / ACCESS Newswire / September 23, 2026 / OMP and PwC have formed an alliance to bring unified, faster supply chain decisions to process manufacturers in life sciences, consumer goods, and chemicals. Planning in these industries runs on campaign production, long lead times, and regulatory requirements, all surfacing "too late to act on" when planning sits in separate systems. The alliance combines Unison Planning™, OMP's AI-enabled planning platform with built-in industry expertise, and PwC's implementation services.
German specialty pharmaceutical company medac is already live under the alliance, with its planners working on a single demand plan in Unison Planning™. PwC and medac will present the project on October 15, 2026, at the OMP Conference in Singapore, detailing the approach behind the rollout and what it means for planning in pharma.
Combining innovation, industry knowledge, and integration
OMP and PwC run each implementation as a single program. OMP brings Unison Planning™, its AI-enabled platform with built-in industry expertise, connecting to the systems that a manufacturer already runs. PwC's teams lead the implementation, acting as system integrator and working directly alongside the customer's own planners.
Both organizations see the same shift across life sciences, consumer goods, and chemicals: manufacturers replacing fragmented planning with a unified end-to-end plan, and looking for a platform and an implementation team that already know their industry.
"Process manufacturers face the same planning constraints, whatever their size, and few have spare program capacity to absorb an implementation. That is where the combination of the platform, the industry knowledge, and an integrator who can run the program matters most," said Dieter Sleeuwaert, Senior Vice President Global Alliances at OMP.
medac moves from spreadsheets to a single demand plan
medac supplies specialty treatments in rheumatology, urology, hematology, and oncology to more than 90 countries, manufacturing at its own European sites. Its planning ran on a mix of spreadsheets, planning functions within its existing ERP system, and a separate tool with limited planning capability. Processes also differed by department and by geography.
PwC, medac and OMP started with a focused demand planning release, resulting in an accelerated go-live for German planners ahead of the wider rollout. The remaining geographies, a supply planning layer, and a second release running in parallel with medac's SAP S/4 implementation will follow.
"Leading with the demand planning release and holding the solution close to standard is what made it work. That approach transfers to other companies in the sector," said Jörg Zietz, Director, Supply Chain Planning at PwC Germany.
PwC and medac on stage in Singapore
Dr. Karsten Gentner, Vice President Supply Chain Management and Procurement at medac, and Jörg Zietz of PwC Germany will explain how medac is building the digital backbone for a smarter, more resilient, and AI-ready pharmaceutical supply chain. Their session takes place on October 15, 2026 at the OMP Conference in Singapore. Register for the event.
About PwC
At PwC, we help clients build trust and reinvent so they can turn complexity into a competitive advantage. We're a tech-forward, people-empowered network with more than 364,000 people in 136 countries and 137 territories. Across audit and assurance, tax and legal, deals and consulting, we help clients build, accelerate, and sustain momentum.
About medac
The medac Group is committed to improving patients' quality of life worldwide by providing access to the best possible medical therapies. As a globally operating pharmaceutical company headquartered in Germany, we are active in more than 90 countries and employ over 2,000 people worldwide. With production sites in Europe and a focus on rheumatology, urology, hematology, and oncology, medac develops and markets high-quality originator products, generics, and biosimilars.
About OMP
OMP helps companies facing complex planning challenges to excel, grow, and thrive by offering the best digitized supply chain planning solution on the market. Hundreds of customers in a wide range of industries - spanning consumer goods, life sciences, chemicals, metals, paper, packaging, plastics, tires, and building products - benefit from using OMP's unique Unison Planning™.
Solution and product inquiries
Contact OMP
+32 3 650 22 11
Media inquiries
Kira Perdue (Carabiner)
SOURCE: OMP
View the original press release on ACCESS Newswire
P.Petrenko--CPN